date,title,source
Oct-31-18,Scholar Rock to Present at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-09-18,Scholar Rock Demonstrates that Highly Specific TGF1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade Therapy,GlobeNewswire
Nov-19-18,Scholar Rock Announces the Addition of Edward (Ted) Myles to Its Board of Directors,GlobeNewswire
Nov-27-18,Scholar Rock Announces Publication of Preclinical Data on the Therapeutic Benefit of Inhibiting Myostatin Activation in Models of Spinal Muscular Atrophy,GlobeNewswire
Nov-29-18,Scholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare Conference,GlobeNewswire
Dec-03-18,Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy,GlobeNewswire
Dec-19-18,Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases,Business Wire
Dec-20-18,Raymond James: Gilead In NASH For The Long Haul,Benzinga
Dec-26-18,"Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal",Zacks
Dec-28-18,"Why Cabot Oil & Gas, Uxin, and Scholar Rock Holding Slumped Today",Motley Fool
Jan-03-19,Gilead Stock Breaks Out to Channel Resistance,Investopedia
Jan-03-19,Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-04-19,Read This Before Selling Scholar Rock Holding Corporation (NASDAQ:SRRK) Shares,Simply Wall St.
Feb-15-19,Sarepta's NDA for DMD Drug Golodirsen Gets Priority Review,Zacks
Feb-26-19,Scholar Rock Announces Positive Interim Results from Phase 1 Trial of SRK-015 in Healthy Volunteers and Updates on Future Development Plans,GlobeNewswire
